Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Novo Nordisk expands social media efforts with new Twitter account

Danish pharma company's US business joins the social network

Novo Nordisk US Twitter account

Novo Nordisk has expanded its social media efforts, launching a new Twitter account for its US business.

It joins the Danish pharma company's existing accounts on the social network, which focus on corporate sustainability, graduate recruitment, and government affairs and public policy.

Its most note-worthy US social media initiative to date has been its sponsorship of Race with Insulin, which is pharma's first – and, so far, only – branded Twitter account.

Run by Indy car driver, and Novo-paid spokesman, Charlie Kimball, who has type I diabetes, the Twitter account's background currently features branding for the NovoLog Flexpen.

Novo's new Twitter account will be run by its US media relations and corporate communications director Ken Inchausti and focus on “news and views on diabetes and chronic disease for US audiences”.

• Links to Novo's new Twitter account and its existing social media initiatives can be found in the Digital Handbook's pharma social media directory

30th April 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics